Tuberkuloz ve Toraks-Tuberculosis and Thorax

Scope & Guideline

Elevating knowledge in pulmonary and critical care.

Introduction

Welcome to the Tuberkuloz ve Toraks-Tuberculosis and Thorax information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Tuberkuloz ve Toraks-Tuberculosis and Thorax, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageMulti-Language
ISSN0494-1373
PublisherTURKISH ASSOC TUBERCULOSIS & THORAX
Support Open AccessNo
CountryTurkey
TypeJournal
Convergefrom 2003 to 2024
AbbreviationTUBERK TORAK / Tuberk. Toraks
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressC/O AKIN KAYA MD, PROFESSOR, DEPT CHEST DISEASES, FAC MEDICINE, ANKARA 06100, Turkiye

Aims and Scopes

The journal 'Tuberkuloz ve Toraks-Tuberculosis and Thorax' focuses on a broad spectrum of respiratory diseases, with a particular emphasis on tuberculosis and related pulmonary conditions. Its aims include advancing knowledge in the field through clinical studies, reviews, and innovative research methodologies.
  1. Tuberculosis Research:
    A core focus of the journal is on tuberculosis, including its diagnosis, treatment, and complications. Studies often explore novel therapeutic approaches and public health strategies to combat TB.
  2. Respiratory Disease Management:
    The journal covers various aspects of managing chronic respiratory diseases such as asthma, COPD, and interstitial lung diseases, emphasizing clinical outcomes and patient management strategies.
  3. Pulmonary Pathophysiology and Diagnostics:
    Research on the underlying pathophysiological mechanisms of respiratory diseases, alongside advances in diagnostic techniques like imaging and biomarkers, is a consistent theme.
  4. COVID-19 Impact and Related Respiratory Conditions:
    Given the recent pandemic, there is a significant focus on the effects of COVID-19 on respiratory health, including long-term sequelae and management strategies.
  5. Innovative Therapeutics and Technologies:
    The journal promotes studies on the latest therapeutic innovations, including biologics and personalized medicine, particularly in the treatment of severe asthma and other chronic conditions.
Recent years have seen the emergence of new themes within the journal, reflecting current trends in respiratory medicine and public health. These topics highlight the evolving landscape of research priorities.
  1. Long COVID and Post-COVID Conditions:
    There is a growing body of literature addressing the long-term effects of COVID-19, including post-COVID syndrome, which is crucial for understanding and managing ongoing respiratory issues.
  2. Telemedicine and Remote Patient Monitoring:
    The shift towards telemedicine, particularly during and after the pandemic, has led to increased research on its effectiveness in managing respiratory diseases and enhancing patient care.
  3. Biologics and Targeted Therapies:
    Research on the use of biologics for severe asthma and other conditions is on the rise, reflecting a trend towards personalized medicine and targeted treatment approaches.
  4. Impact of Environmental Factors on Respiratory Health:
    Emerging studies explore how environmental factors, such as air pollution and climate change, affect respiratory health, indicating a significant shift towards public health and environmental health intersections.
  5. Artificial Intelligence in Pulmonology:
    The application of AI and machine learning in diagnosing and managing respiratory diseases is gaining traction, with studies focusing on its potential to enhance diagnostic accuracy and treatment outcomes.

Declining or Waning

While the journal maintains a diverse range of topics, certain themes have seen a decline in recent publications. These areas may reflect shifting research priorities or reduced interest in specific methodologies or conditions.
  1. Traditional Epidemiological Studies:
    There appears to be a decline in traditional epidemiological studies focused solely on the prevalence of respiratory diseases, as newer methodologies and technologies gain traction.
  2. Basic Science Research on Respiratory Diseases:
    Research that emphasizes basic science or laboratory studies without direct clinical application has become less prominent, as the journal increasingly prioritizes studies with immediate clinical relevance.
  3. Niche Respiratory Conditions:
    Coverage of less common respiratory conditions, such as rare lung diseases, has diminished in favor of more prevalent conditions and those with greater public health impact.

Similar Journals

THORAX

Elevating respiratory research to new heights.
Publisher: BMJ PUBLISHING GROUPISSN: 0040-6376Frequency: 12 issues/year

THORAX is a premier academic journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine. Published by the esteemed BMJ Publishing Group in the United Kingdom, this journal has been a pivotal resource for researchers and clinicians since its inception in 1946. With a remarkable ranking of #6 out of 155 in its category, THORAX holds a prestigious position within the top 4% of its field, as indicated by its 2023 Q1 quartile classification and a strong Scopus ranking. The journal focuses on publishing high-quality research, reviews, and clinical studies that are essential for understanding respiratory diseases and their management. Although it is not an open-access journal, THORAX provides vital contributions to the academic community, fostering dialogue and innovation in pulmonary medicine. As it approaches its converged years, concluding in 2024, researchers, professionals, and students are encouraged to explore its rich repository of knowledge, while engaging with the most current advancements in the field.

Pulmonology

Leading the way in open-access research for respiratory disorders.
Publisher: ELSEVIERISSN: 2531-0437Frequency: 6 issues/year

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.

EUROPEAN RESPIRATORY JOURNAL

Transforming Respiratory Health Through Science
Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTDISSN: 0903-1936Frequency: 12 issues/year

The EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.

Jornal Brasileiro de Pneumologia

Championing excellence in pulmonary and respiratory research.
Publisher: SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIAISSN: 1806-3713Frequency: 6 issues/year

Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.

Multidisciplinary Respiratory Medicine

Advancing respiratory health through collaborative research.
Publisher: MATTIOLI 1885ISSN: 1828-695XFrequency: 1 issue/year

Multidisciplinary Respiratory Medicine is a leading open-access journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by MATTIOLI 1885, this journal has been serving the academic community since 2008 and has become a vital platform for the dissemination of research and clinical insights in this critical area of healthcare. With an impressive impact factor placing it in the Q2 category of pulmonary medicine in 2023 and a Scopus rank of #67 out of 155, it reflects a solid commitment to high-quality research. The journal provides researchers, health professionals, and students with accessible and updated information, fostering collaboration and advancement in respiratory health. Operating from the United Kingdom, it has embraced open access since 2010, ensuring that all articles are freely available, thus maximizing the reach and impact of its scholarly contributions. Whether you are looking to publish innovative findings or gain insights from industry leaders, Multidisciplinary Respiratory Medicine is your go-to resource for the latest in respiratory science.

RESPIRATORY RESEARCH

Bridging Research and Clinical Excellence in Respiratory Care
Publisher: BMCISSN: Frequency: 1 issue/year

RESPIRATORY RESEARCH is a leading open-access journal published by BMC, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2000, this journal has provided a vital platform for disseminating high-quality research, covering a broad spectrum of topics from basic science to innovative clinical practices in respiratory health. With an impressive impact factor and a Q1 ranking in the Pulmonary and Respiratory Medicine category, RESPIRATORY RESEARCH is recognized for its significant contribution to the literature, currently positioned at rank #19 out of 155 in the Scopus database, highlighting its relevance and influence within the medical community. The journal’s commitment to open access ensures that all articles are freely available to researchers, professionals, and students, fostering collaboration and knowledge sharing in the field. With its convergence years spanning from 2000 to 2024, RESPIRATORY RESEARCH remains at the forefront of respiratory medicine research, making it an essential resource for all stakeholders in this vital medical domain.

RESPIRATORY MEDICINE

Championing Excellence in Pulmonary Research
Publisher: W B SAUNDERS CO LTDISSN: 0954-6111Frequency: 12 issues/year

Respiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.

Annals of the American Thoracic Society

Advancing pulmonary health through innovative research.
Publisher: AMER THORACIC SOCISSN: 1546-3222Frequency: 12 issues/year

Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.

Turkish Thoracic Journal

Exploring the forefront of thoracic research and clinical practice.
Publisher: AVESISSN: Frequency: 6 issues/year

Turkish Thoracic Journal, published by AVES, is a prominent open-access platform dedicated to advancing the field of pulmonary and respiratory medicine. Since its establishment, the journal has aimed to disseminate significant research findings, clinical studies, and reviews that contribute to an improved understanding of respiratory health challenges, with a particular focus on the Turkish context and regional issues. With an E-ISSN of 2149-2530 and transitioning to open access in 2022, the journal enhances visibility and accessibility, inviting a global audience of researchers, clinicians, and students to engage with the latest scientific work. The Turkish Thoracic Journal has been indexed in major databases, although it faced a coverage discontinuation in Scopus between 2016 and 2022. Currently positioned within the 23rd percentile among its peers in the field, it invites submissions that explore innovative approaches to thoracic health, enriching the discourse in a vital area of medicine.

Zeitschrift fur Pneumologie

Catalyzing Change in Pulmonary Health Research
Publisher: SPRINGER HEIDELBERGISSN: 2731-7404Frequency: 6 issues/year

Zeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.